Abstract:Jintao Huang, 1, * Chaoxi Wu, 2, * Shunqing Tang, 3 Pengjun Zhou, 2 Jianping Deng, 1 Zhen Zhang, 1 Yifei Wang, 2 Zhiping Wang 1 1 Guangdong Provincial Engineering Center of Topical Precise Drug Delivery System, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510632, People's Republic of China; 2 Guangzhou Jinan Biomedicine Research and Development Center, Institute of Biomedicine, College of Life Science and Technology, Jinan University, Guangzhou 510632, People's Republic of China; 3 Biomedical Engineering Institute, Jinan University, Guangzhou 510632, People's Republic of China *These authors contributed equally to this work Correspondence: Yifei Wang; Zhiping Wang Email twang-yf@163.com; wzping-jshb@gdpu.edu.cn Background: β-glucans are chiral polysaccharides with well-defined immunological properties and supramolecular wrapping ability of its chiral feature. However, the exploitation of chiral properties of these nanoparticles in drug delivery systems was seldom conducted. Methods: β-glucan molecules with different chain lengths were extracted from yeast Saccharomyces cerevisiae and thereafter modified. In a conformation transition process, these β-glucan molecules were then self-assembled with anti-cancer drug doxorubicin into nanoparticles to construct drug delivery systems. The chiral interactions between the drug and carriers were revealed by circular dichroism spectra, ultraviolet and visible spectrum, fourier transform infrared spectroscopy, dynamic light scattering and transmission electron microscope. The immune-potentiation properties of modified β-glucan nanoparticles were evaluated by analysis of the mRNA expression in RAW264.7 cell model. Further, the antitumor efficacy of the nanoparticles against the human breast cancer were studied in MCF-7 cell model by cellular uptake and cytotoxicity experiments. Results: β-glucan nanoparticles can activate macrophages to produce immune enhancing cytokines (IL-1β, IL-6, TNF-α, IFN-γ). A special chirality of the carriers in diameter of 50∼ 160 nm can also associate with higher drug loading ability of 13.9% ∼ 38.2% and pH-sensitive release with a change of pH from 7.4 to 5.0. Cellular uptake and cytotoxicity experiments also prove that the chiral-active β-glucan nanoparticles can be used in anti-cancer nanomedicine. Conclusion: This work demonstrates that β-glucans nanoparticles with special chiral feature which leading to strong immunopotentiation ability and high drug loading efficiency can be developed as a novel type of nanomedicine for anti-cancer treatment. Keywords: β-glucan, chiral, nanoparticles, doxorubicin, anti-cancer, drug delivery systems, immune-potentiation

Enhanced Phagocytosis and Endosomal Escape of Glucan-Modified Microparticles in Antigen-Presenting Cells

Characterization and optimization of the glucan particle-based vaccine platform.

Particulate Β-Glucan Activates Early and Delayed Phagosomal Maturation and Autophagy Within Macrophage in a NOX-2 Dependent Manner

β-glucan-modified nanoparticles with different particle sizes exhibit different lymphatic targeting efficiencies and adjuvant effects

Antigen presenting cell-selective drug delivery by glycan-decorated nanocarriers

Glucans and applications in drug delivery

Glucosylation Endows Nanoparticles with TLR4 Agonist Capability to Trigger Macrophage Polarization and Augment Antitumor Immunity

Macrophage membrane-coated Eucommia ulmoides polysaccharides-loaded PLGA nanoparticles as an effective antigen-targeted delivery system

Yeast β-Glucan-Grafted Glycogen Nanoparticles for Macrophage-Targeted Precise Delivery of CpG Oligodeoxynucleotides: Implications for Immunotherapy Applications

The impact of size for liposomes modified with pH-responsive β-glucan derivatives on the initiation of cellular and humoral immune responses in murine models

Uptake Quantification of Antigen Carried by Nanoparticles and Its Impact on Carrier Adjuvanticity Evaluation

Shape Effect of Glyco-Nanoparticles on Macrophage Cellular Uptake and Immune Response.

Aminated yeast β-D-glucan for macrophage-targeted delivery of CpG oligodeoxynucleotides and synergistically enhanced cancer immunotherapy

Yeast glucan particles: An express train for oral targeted drug delivery systems

Effect of partial PEGylation on particle uptake by macrophages.

In situ self-assembly of peptides in glucan particles for macrophage-targeted oral delivery

Preparation of glycopeptide-modified pH-sensitive liposomes for promoting antigen cross-presentation and induction of antigen-specific cellular immunity

Glycopolymeric Nanoparticles Enrich Less Immunogenic Protein Coronas, Reduce Mononuclear Phagocyte Clearance, and Improve Tumor Delivery Compared to PEGylated Nanoparticles

Influence of Polyethyleneglycol Modification on Phagocytic Uptake of Polymeric Nanoparticles Mediated by Immunoglobulin G and Complement Activation.

Macrophage membrane coated discoidal polymeric particles for evading phagocytosis

Chiral Active β-Glucan Nanoparticles for Synergistic Delivery of Doxorubicin and Immune Potentiation